Back to top

Niagen Bioscience launches pharmaceutical program for aging and genetic diseases

Niagen Bioscience (NAGE) formally launched the first drug candidate of NAD Pharmaceuticals, its wholly owned subsidiary focused on developing thera...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Niagen Bioscience, Inc. (NAGE)